Health
COVID-19: EU Still Testing Pfizer Vaccine, Keeps 2021 Forecast
Published
5 years agoon
By
Mega IconThe European Medicines Agency is still reviewing the safety of a Covid-19 vaccine submitted by Pfizer and BionNTech and has not received clinical trial data, EU sources said Monday.
A “rolling review” of several potential vaccines is underway and, for now, Brussels is sticking by its forecast that one may be approved and available “early next year”, one source said.
Earlier, the companies said that ongoing trials had found that their vaccine was 90 percent effective in preventing Covid-19 infections, sending hopes soaring for an end to the epidemic.
The European Medicines Agency (EMA) has begun an expedited procedure to examine potential vaccines, and did nothing to pour cold water on reports of a breakthrough.
But a spokeswoman for the Amsterdam-based agency said they had yet to receive the results of clinical trials.
“Through rolling reviews, EMA can exceptionally evaluate data as it becomes available, ahead of a formal marketing-authorisation application,” she said.
“We evaluated the first batch of data on the vaccine, which came from laboratory studies (non-clinical data).
“The agency is currently assessing a second batch of data which relate to the quality of the vaccine, including data related to its ingredients and the way it is produced.
“Any new data available for this vaccine will be reviewed in the same way. We have not received nor assessed the emerging clinical data at this point and can therefore not comment further.”
Separately, in Brussels, a European source confirmed this and added “any prediction would be risky, but we have good indications that the first vaccine may be available early next year.”
European officials, including the president of the European Commission Ursula von der Leyen have previously used this timeline when talking about a future vaccine.
And Brussels has put funding aside to reserve tens of millions of doses of future vaccines from several companies, including that from US giant Pfizer and its German partner BioNTech.
AFP
Related
Health
Oyo confirms Lassa fever death in Ibadan, activates emergency response, traces contacts
Published
6 days agoon
April 16, 2026By
Mega IconThe Oyo State Government has confirmed a Lassa fever case at the University College Hospital, Ibadan, where a 44-year-old woman died, prompting the activation of emergency response measures and immediate contact tracing to contain the disease.
The state Commissioner for Health, Oluwaserimi Ajetunmobi, disclosed this in a statement on Wednesday, saying, “The patient died on April 11, 2026, while receiving treatment, while laboratory confirmation of Lassa fever was received on April 13.”
She added that the Ministry of Health had swiftly activated its emergency response system, including the establishment of an Incident Management System to coordinate response activities across the state.
According to her, “All identified contacts of the deceased are being closely monitored, while necessary measures have been taken to ensure a safe and dignified burial in line with public health protocols.”
Ajetunmobi urged residents to seek immediate medical attention if they experience symptoms such as persistent fever, weakness, sore throat, vomiting, diarrhoea, unexplained bleeding, chest pain or difficulty breathing.
She stressed, “Early presentation at health facilities significantly improves the chances of survival.”
The commissioner explained that Lassa fever is a viral haemorrhagic disease transmitted primarily through contact with food or household items contaminated by urine or faeces of infected rodents.
“It can also spread from person to person through contact with bodily fluids, especially in healthcare settings where infection prevention measures are not strictly observed,” she said.
She advised residents to maintain strict environmental hygiene, including proper waste disposal, safe storage of food in rodent-proof containers and avoiding drying food items on bare ground or roadsides.
Ajetunmobi also urged households to seal holes and entry points to prevent rodent access, while emphasising regular handwashing and good personal hygiene.
Residents, she said, should report suspected cases through designated emergency lines, while health workers must strictly adhere to infection prevention and control protocols.
Reaffirming the government’s commitment, the commissioner said surveillance had been intensified across the state, with all health facilities placed on alert.
“There is no cause for panic. The situation is under control, and Lassa fever is both preventable and treatable when detected early,” she assured.
Related
Health
Rep Oseni Backs Ajimobi Widow’s Cancer Fight, Vows More Health Projects
Published
7 months agoon
October 2, 2025By
Mega IconThe lawmaker representing Ibarapa East/Ido Federal Constituency in the House of Representatives, Aderemi Oseni, has pledged to support the breast cancer awareness programme of the ABC Foundation founded by former Oyo First Lady, Dr. Florence Ajimobi.
Oseni, who is Chairman of the House Committee on Federal Roads Maintenance Agency (FERMA), made the commitment on Thursday in Ibadan at the flag-off of Pink Month 2025, an initiative of the foundation.
Contained in a statement by his media aide, Idowu Ayodele, the lawmaker described the campaign as a “lifesaving mission” given the rising burden of breast cancer in Nigeria, with over 28,000 new cases and thousands of deaths reported annually.
The APC chieftain said the free screening of 1,000 women planned by the foundation was timely, stressing that early detection remained the strongest weapon in the fight against cancer.
Hon. Aderemi Oseni exchanging pleasantries with former Oyo State First Lady, Dr. (Mrs.) Florence Ajimobi, at the event.
“Health is life. Only this June, I moved a motion at the National Assembly which led to the Federal Government subsidising dialysis treatment nationwide. Today, dialysis is either free or heavily discounted in federal health facilities,” Oseni said.
He listed his personal interventions to include funding hospital bills of indigent patients, construction of hospitals in Ido and Ibarapa East, establishment of primary health centres, and organisation of medical outreaches. He also disclosed plans to deploy mobile clinics to rural areas.
Commending Mrs. Ajimobi for sustaining her late husband’s legacy through humanitarian service, Oseni assured of partnership with the foundation, saying women’s wellbeing and empowerment remained central to his vision for Oyo State.
In her remarks, Mrs. Ajimobi said the foundation had offered medical care to over 85,000 patients and conducted more than 100,000 investigations since its inception. She added that the campaign was not just corporate social responsibility but “a moral duty and sacred trust.”
The former first lady, who lost her daughter Abisola to breast cancer earlier this year, said the experience had strengthened her resolve to save other families from such tragedy. She appealed to women to take advantage of the free screening and called on partners and development agencies to support the fight.
Related
Health
Ayebae, Afolabi to headline D’Bio Wellness Summit
Published
7 months agoon
September 22, 2025By
Mega Icon
Chairman of Fidson Healthcare Plc, Dr. Fidelis Akhagboso Ayebae, and Chief Executive Officer of Hazon Holdings, Dr. Victor ’Gbenga Afolabi, are set to lead discussions at the second edition of the D’Bio Wellness & Selfcare Summit.
The event is scheduled to hold on September 24 and 25 at the Lagos Chamber of Commerce and Industry (LCCI) Conference and Exhibition Centre, Alausa, Ikeja.
This year’s summit has the theme: “Self-Care as a Driver of Optimal Health and Wellness.”
Ayebae will serve as chairman of the event, while Afolabi, who is also the co-founder of Wellness HMO, will deliver the keynote address.
Ayebae, founder of Fidson Healthcare, is regarded as one of Nigeria’s leading pharmaceutical entrepreneurs. He is a fellow of the Institute of Directors Nigeria and the Institute of Corporate Affairs Management, and has held significant roles in the Manufacturers Association of Nigeria.
Afolabi has more than 20 years’ experience spanning healthcare, finance, technology and marketing. He is also the founder of the Eko Innovation Centre, a Lagos-based technology hub that supports start-ups and young entrepreneurs.
Convener of the summit, Dr. Monica Hemben Eimunjeze, said the event would focus on practical steps to improve health outcomes through self-care.
She said, “We are excited to welcome Dr. Ayebae and Dr. Afolabi as pivotal figures in our quest to enhance health literacy and empower individuals to prioritise self-care. This summit is not just about discussions; it is about actionable insights that can inspire and transform lives.”
The organisers said the two-day summit is open to the public and will feature panel sessions with health and wellness experts, attracting healthcare professionals, advocates and business leaders.
Related
Advertisement
Entertainment
Adekunle Gold, Simi welcome twins
Ayefele drops new album, Reflections
Reggae Legend, Jimmy Cliff, Dies At 81
Photos: Davido blows $3.7m on lavish Miami white wedding for Chioma
FAAN probes K1 for spilling alcohol on airport officer during boarding
Odunlade Adekola loses father
MegaIcon Magazine Facebook Page
MEGAICON TV
Advertisement
Trending
-
News6 days agoOseni Secures Prestigious City People Political Award Nomination
-
Health6 days agoOyo confirms Lassa fever death in Ibadan, activates emergency response, traces contacts
-
Politics2 days ago2027: Oseni kicks off Oyo South Senate bid, rallies support for one million Tinubu votes
-
Crime & Court6 days agoJoshua crash: Driver faces fresh charges as court adjourns trial